Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
Anti-stigma programs have exploded in the United States as well as across
the world in the past decade. Now needed is a more strategic approach to stigma
change, consideration of evaluation strategies that demonstrate its effectiveness.
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international a...nd national levels.
Dementia is a syndrome that affects memory, thinking, behaviour and ability to perform everyday activities. The number of people living with dementia worldwide is currently estimated at 35.6 million. This number will double by 2030 and more than triple by 2050. Dementia is overwhelming not only for the people who have it, but also for their caregivers and families. There is lack of awareness and understanding of dementia in most countries, resulting in stigmatization, barriers to diagnosis and care, and impacting caregivers, families and societies physically, psychologically and economically.
Available Languages: Chinese, English, Japanese, Russian and Spanish
more
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Réduction des risques, promotion de la résilience et aide au relèvement
Élargir l’accès aux soins pour
lutter contre les troubles mentaux,
neurologiques et liés à l’utilisation
de substances psychoactives
El Programa de acción mundial para superar las brechas en salud mental (mhGAP)1 fue
lanzado por la Organización Mundial de la Salud (OMS) en el año 2008. En 2010, se
lanzó la Guía de Intervención mhGAP (GI‐mhGAP) (1) y se comenzó a aplicar en cinco
países (Etiopía, Jordania, Nigeria, P...anamá y Sierra Leona) dentro de un proyecto
piloto, bajo la supervisión de la OMS. Panamá lo puso en funcionamiento utilizando la
versión española del mhGAP; los otros cuatro países usaron la versión inglesa1.
more
Rapport mondial sur les drogues 2018
Externalising disorders
Chapter D.3
Introducción
Capítulo A.2
Edición: Matías Irarrázaval & Andres Martin
Revisión: Fernanda Prieto-Tagle & Miguel Ángel Álvarez
Trastornos externalizantes
Capítulo D.3
Edición: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto Tagle, Sofía Hacohen Domené
Otros trastornos
Capítulo H.2
Editores: Matías Irarrázaval, Daniel F. Martínez Uribe, Andres Martin
Traducción: Jaime J. Gómez Alamán, Begoña Arenas Tuzón, Beatriz Ortega
Otros trastornos
Capítulo H.4
Editores: Laura Borredá Belda, Matías Irarrázaval & Andres Martin
Traductores: Sara Diego Castaño, Laura Álvarez Bravos, Rebeca Santonja & Beatriz Ortega
Otros desórdenes
Capítulo H.6
Editor: Laura Revert Marín, Matías Irarrázaval & Andres Martin
Traducción: Silvia Rodriguez Portillo, Alfonso Pastor Romero y Paula Cox
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA